L2M – Next-Generation iEEG Electrodes with Integrated Optical and Oxygenation Sensors for Precision Neurodiagnostics

This project explores the market opportunity for a next-generation intracranial EEG (iEEG) electrode system that integrates optical and oxygenation sensors to enhance brain monitoring in clinical and research settings. The proposed innovation addresses a critical gap in current neurodiagnostic tools by enabling simultaneous acquisition of electrical activity and hemodynamic signals from the brain. This dual-modality capability has the potential to significantly improve seizure localization in patients with drug-resistant epilepsy and broaden applications in functional brain mapping and brain-computer interface research.

The goal of this Lab2Market Validate project is to conduct focused market research to assess clinical needs, identify early adopters, and evaluate the competitive landscape. Through stakeholder interviews with neurologists, neurosurgeons, clinical researchers, and healthcare technology buyers, we aim to validate the product’s value proposition, understand regulatory considerations, and define key product features that align with user requirements.

Insights gained through this process will inform the development of a commercialization roadmap, including IP strategy, clinical integration pathways, and go-to-market plans. This research will lay the foundation for launching a health technology venture based in Alberta, focused on bringing advanced neurodiagnostic hardware to market with strong clinical impact and global scalability.

Faculty Supervisor:

Pierre LeVan

Student:

Partner:

Edmonton Unlimited

Discipline:

Engineering

Sector:

Professional, scientific and technical services; Public administration

University:

University of Calgary

Program: